NREMT Paramedic
_ Exam Review
Cardiology
& Practice
2026_2027
NREMTQuestions.pdf
Paramedic
_ Exam Review
Cardiology
& Practice
2026_2027
Questions.pdf
_ Exam Review & Practice Questions.pdf
NREMT Paramedic Cardiology
2026/2027 | Exam Review & Practice
Questions
NREMT Paramedic Cardiology 2026_2027
NREMT Paramedic
_ Exam Review
Cardiology
& Practice
2026_2027
NREMTQuestions.pdf
Paramedic
_ Exam Review
Cardiology
& Practice
2026_2027
Questions.pdf
_ Exam Review & Practice Questions.pdf
,NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf
You respond to a residence for a 68-year-old male with nausea, vomiting, and blurred
vision. As you are assessing him, he tells you that he has congestive heart failure and atrial
fibrillation, and takes numerous medications. The cardiac monitor reveals atrial fibrillation
with a ventricular rate of 50 beats/min. Which of the following medications is MOST likely
responsible for this patient's clinical presentation?
Digoxin.
This patient has classic signs of digitalis toxicity. Digoxin is commonly prescribed to patients
with congestive heart failure and atrial fibrillation (A-Fib) or atrial flutter (A-Flutter). Its
positive inotropic effects increase cardiac contractility and maintain cardiac output, while its
negative chronotropic effects control the ventricular rate of the A-Fib or A-Flutter. Digitalis
preparations (ie, Lanoxin, Digoxin) have a narrow therapeutic index—that is, there is a fine
line between a therapeutic and toxic dose. You should suspect digitalis toxicity in any patient
who takes Digoxin or Lanoxin and presents with complaints such as nausea, vomiting,
abdominal pain, anorexia, or blurred/yellow vision. Additionally, virtually any cardiac
dysrhythmia can be caused by the toxic effects of digitalis. Treatment involves the
administration of Digibind, which is given at the hospital.
NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf
,NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf
Which of the following is an absolute contraindication for fibrinolytic therapy?
Subdural hematoma 3 years ago.
According to current emergency cardiac care (ECC) guidelines, absolute contraindications
for fibrinolytic therapy include ANY prior intracranial hemorrhage (ie, subdural, epidural,
intracerebral hematoma); known structural cerebrovascular lesion (ie, arteriovenous
malformation); known malignant intracranial tumor (primary or metastatic); ischemic stroke
within the past 3 months, EXCEPT for acute ischemic stroke within the past 3 hours;
suspected aortic dissection; active bleeding or bleeding disorders (except menses); and
significant closed head trauma or facial trauma within the past 3 months. Relative
contraindications (eg, the physician may deem fibrinolytic therapy appropriate under certain
circumstances) include, a history of chronic, severe, poorly-controlled hypertension; severe
uncontrolled hypertension on presentation (SBP > 180 mm Hg or DBP > 110 mm Hg); ischemic
stroke greater than 3 months ago; dementia; traumatic or prolonged (> 10 minutes) CPR or
major surgery within the past 3 weeks; recent (within 2 to 4 weeks) internal bleeding;
noncompressible vascular punctures; pregnancy; prior exposure (> 5 days ago) or prior
allergic reaction to streptokinase or anistreplase; active peptic ulcer; and current use of
anticoagulants (ie, Coumadin).
NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf
, NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf
A middle-aged man presents with chest discomfort, shortness of breath, and nausea. You
give him supplemental oxygen and continue your assessment. As your partner is attaching
the ECG leads, you should:
Administer up to 325 mg of aspirin.
Since oxygen has already been administered to this patient and your partner is attaching the
ECG leads, you should administer aspirin (160 to 325 mg, non-enteric-coated). Early
administration of aspirin has clearly been shown to reduce mortality and morbidity in
patients experiencing an acute coronary syndrome (ACS). After establishing vascular access,
you should assess his vital signs and then administer 0.4 mg of nitroglycerin (up to 3 doses, 5
minutes apart), provided that his systolic BP is greater than 90 mm Hg. If 3 doses of
nitroglycerin fail to completely relieve his chest discomfort, consider administering 2 to 4
mg of morphine IV, provided that his systolic BP remains above 90 mm Hg.
NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf NREMT Paramedic_ Cardiology.pdf